Skip to main content
  • 224 Accesses

Zusammenfassung

Die Schilddrüse entwickelt sich aus einer Ausstülpung des Entoderms in der Mitte der Mundbucht in der 3. Woche nach der Konzeption. Nach einer zweilappigen Auf teilung wandert die Schilddrüse vom Ausgangspunkt, dem Foramen coecum, kaudalwärts. Der Ductus thyreoglossus, die Verbindung zwischen Foramen coecum und endgültiger Lage der Schilddrüse etwa in Höhe des 2.-4. Trachealringes, obliteriert postpartal. Nicht selten bildet der kaudale Anteil des Ductus thyreoglossus den Lobus pyramidalis. Beide Schilddrüsenlappen bleiben durch den prä tracheal gelegenen Isthmus verbunden. Die Schilddrüse setzt sich aus zahllosen Follikeln zusammen, die aus einzelnen, aneinander gereihten Zellen bestehen, die einen mit Kolloid gefüllten Hohlraum umgeben. Im Kolloid werden Schilddrüsenhormone im Thyreoglobulinmolekül gespeichert und synthetisiert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur zu Abschn. 4.1

  • Beato M. (1989) Gene regulation by steroid hormones. Cell 56: 335

    Article  PubMed  CAS  Google Scholar 

  • Chopra I.J., Solomon D.H., Chopra U. et al. (1978) Pathways of metabolism of thyroid hormones. Recent Prog Horm Res 34: 521

    PubMed  CAS  Google Scholar 

  • Cody V. (1980) Thyroid hormone interactions: molecular con formation, protein binding and hormone action. Endocr Rev 1: 140

    Article  PubMed  CAS  Google Scholar 

  • Dai G., Levy O., Carrasco N. (1996) Cloning and characterisation of the thyroid iodide symporter. Nature 379: 458–460

    Article  PubMed  CAS  Google Scholar 

  • Dunn A.D., Dunn J.T. (1982) Thyroglobulin degradation by thyroidal proteases: action of thiol endopeptidases in vitro. Endocrinology 111: 290

    Article  PubMed  CAS  Google Scholar 

  • Evans E.M. (1988) The steroid and thyroid hormone reeeptor superfamily. Science 240: 889

    Article  PubMed  CAS  Google Scholar 

  • Hinkle P.M., Perrone M.H., Schonbrunn A. (1981) Mechanism of thyroid hormone inhibition of thyrotropin-releasing hormone action. Endocrinology 108: 199

    Article  PubMed  CAS  Google Scholar 

  • Köhrle J., Brabant G., Hesch H.D. (1987) Metabolism of thyroid hormones. Hormone Res 26: 58

    Article  PubMed  Google Scholar 

  • Lama L., Taurog A. (1977) The importance of thyroglobulin structure in thyroid peroxidase-catalysed conversion of diiodotyrosine to thyroxine. Endocrinology 100: 1129

    Article  Google Scholar 

  • Laurberg P. (1984) Mechanisms governing the relative proportions of thyroxine and 3,5,3’. triiodothyronine in thyroid secretion. Metabolism 33: 379

    Article  PubMed  CAS  Google Scholar 

  • Leonard J.L., Meilen S.A., Larsen P.R. (1983) Thyroxine 5’-deiodinase activity in brown adipose tissue. Endocrinology 112: 1153

    Article  PubMed  CAS  Google Scholar 

  • Magner J.A. (1990) Thyroid-stimulating hormone: biosynthesis, cell biology and bioactivity. Endocr Rev 11: 354

    Article  PubMed  CAS  Google Scholar 

  • Nunez J., Pommier J. (1982) Formation of thyroid hormones. Vitam Horm 39: 175

    Article  PubMed  CAS  Google Scholar 

  • Roti E., Gnudi A., Bravermann L.E. (1983) The placental transport, synthesis, and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 4: 131

    Article  PubMed  CAS  Google Scholar 

  • Sakurai A., Nakai A., DeGroot L.J. (1990) Structural analysis of human thyroid hormone rcccplor beta gene. Mol Cell Endocrinol 71: 83

    Article  PubMed  CAS  Google Scholar 

  • Sap J., Munoz A., Damm K. et al. (1986) Ther c-erb-A protein is a high affinity receptor for thyroid hormone. Nature 324: 635

    Article  PubMed  CAS  Google Scholar 

  • Snyder S.M., Cavalieri R.R., Goldfine I.D., Ingbar S.H., Jorgensen S.E. (1976) Binding of thyroid hormones and their analogues to thyroxine-binding globulin in human serum. J Biol Chem 251: 6489

    PubMed  CAS  Google Scholar 

  • Uchimura H., Chiu S.C., Kuzuya N., Ikeda H., Ito K., Nagataki S. (1980) Effect of iodine enrichment in vitro on the ade nylate cyclase-adenosine 3’, 5’ monophophate system in thyroid glands from normal subjects and patients with Graves’ disease. J Clin Endocrinol Metab 50: 1066

    Article  PubMed  CAS  Google Scholar 

Literatur zu Abschn. 4.2-4.7

  • Ahlbom B.D., Yaqoob M., Larsson A., Ilicki A., Anneren G., Wadelius C. (1997) Genetic and !inkage analysis of familial congenital hypothyroidism: exclusion of !inkage to the TSH receptor gene. Hum Genet 99: 186–190

    Article  PubMed  CAS  Google Scholar 

  • Amino N., Mori H., Iwatani Y. et al. (1982) High prevalence of transient postparturn thyrotoxicosis and hypothyroidism. N Engl J Med, 306: 849–852

    Article  PubMed  CAS  Google Scholar 

  • Badenhoop K., Schwarz G., Walfish P.G. et al. (1990) Susceptibility to thyroid autoimmune disease: moleeular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto’s thyroiditis. J Clin Endocrinol Metab 71: 1131–1137

    Article  PubMed  CAS  Google Scholar 

  • Baker J.R. (1992) Immunologie aspects of endocrine disease. JAMA 25: 2899–2903

    Article  Google Scholar 

  • Bartalena L., Brogioni S., Grasso L., Bogazzi F., Burelli A., Martino E. (1996) Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: Results of a prospective study. J Clin Endocrinol Metab 81: 2930–2933

    Article  PubMed  CAS  Google Scholar 

  • Basgoz N., Swartz M.N. (1996) Infections of the thyroid gland. In: Braverman L.E., Utiger R.D. (Hrsg) Werner and Ingbar’s the thyroid. 7th edn, Lippincott & Raven, Philadelphia, pp 1049–1056

    Google Scholar 

  • Berger S.A., Zonzein J., Villamena P., Mittman N. (1983) Infectious diseases of the thyroid gland. Rev Infect Dis 5: 108–122

    Article  PubMed  CAS  Google Scholar 

  • Biebermann H., Schoneberg T., Krude H., Schultz G., Gudermann T., Grüters A. (1997) Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 82: 3471–3480

    Article  PubMed  CAS  Google Scholar 

  • Brander A. (1992) Ultrasound appearances in de Quervain’s subacute thyroiditis with longterm follow-up. J Intern Med 232: 321–325

    Article  PubMed  CAS  Google Scholar 

  • Dayan C.M., Daniels G.H. (1996) Chronie auto immune thyroiditis. N Engl J Med 335: 99–107

    Article  PubMed  CAS  Google Scholar 

  • De Bruin T.W.A., Rieckhoff F.P.M., DeBoer J.J. (1990) An outbreak of thyrotoxicosis due to atypical subacute thyroiditis. J Clin Endocrinol Metab 70: 396–402

    Article  PubMed  Google Scholar 

  • De Catte L., De Wolf D., Smitz J., Bougatef A., De-Schepper J., Foulon W. (1994) Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. Prenat Diagn 14: 762–765

    Article  PubMed  Google Scholar 

  • DeGroot L.I., Quintans J. (1990) The causes of auto immune thyroid disease. Endocr Rev 10: 537–562

    Article  Google Scholar 

  • Delange F. (1997) Neonatal screening for congenital hypothyroidism: results and perspectives. Horm Res 48: 51–61

    Article  PubMed  CAS  Google Scholar 

  • Gärtner R. (1992) Post-partum-Thyreoiditis-Definition. Häufigkeit und klinische Bedeutung. Internist 33: 100–102

    PubMed  Google Scholar 

  • Giordano C., Stassi G., Demaria R. et al.(1997) Potential involvement of fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science 275: 960–963

    PubMed  CAS  Google Scholar 

  • Gladwin M.T., Duell P.B. (1996) Inappropriate thyroid gland ablation in patients with generalized resistance to thyroid hormone. A common sequela of a rare dis order. Arch Intern Med 156: 106–109

    Article  PubMed  CAS  Google Scholar 

  • Glinoer D., Riahi M., Grün J.P. (1994) Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid dis orders. J Clin Endocrinol Metab 79: 197–204

    Article  PubMed  CAS  Google Scholar 

  • Gutekunst R., Hafermann W., Mansky T., Scriba P.C. (1989) Ultrasonography related to clinical and laboratory findings in lymphocytic thyroiditis. Acta Endocrinol 121: 129–135

    PubMed  CAS  Google Scholar 

  • Harjai K.J., Licata A.A. (1997) Effects of amiodarone on thyroid function. Ann Intern Med 126: 63–73

    Article  PubMed  CAS  Google Scholar 

  • Hay I.D. (1985) Thyroiditis: a clinical update. Mayo Clin Proc 60: 836–843

    Article  PubMed  CAS  Google Scholar 

  • Hehrmann-R. (1996) Myxödem-Koma-eine seltene Komplikation der Hypothyreose. Mögliche iatrogene Auslösefaktoren beachten. Fortsehr Med 114: 474–478

    CAS  Google Scholar 

  • Heller J., Musiolik J., Homrighausen A., Sauerbruch T., Spengler U. (1996) Vorkommen und Bedeutung von Autoantikörpern im Rahmen der Interferontherapie der chronischen Hepatitis C. Dtsch Med Wschr 121: 1179–1183

    Article  PubMed  CAS  Google Scholar 

  • Heufelder A.E., Hay I.D. (1994) Evidence for autoimmune mechanisms in the evolution of invasive fibrous thyroiditis (Riedel’s struma). Clin Invest 72: 788–793

    Article  CAS  Google Scholar 

  • Heufelder, Armin E., Hofbauer, Lorenz C. (1998) Die Thyreoiditiden: Aktueller Stand der Pathogenese, Diagnostik und Therapie. Dt Ärztebl 95:A466–A476

    Google Scholar 

  • Jansson R., Bernander S., Karlsson A. et al. (1984) Autoimmune thyroid dysfunction in the postparturn period. J Clin Endocrinol Metab 58: 681–687

    Article  PubMed  CAS  Google Scholar 

  • Jordan R.M. (1995) Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am 79: 185–194

    PubMed  CAS  Google Scholar 

  • Kasagi K., Kousaka T., Higuchi K. et al. (1996) Clinical significance od measurements of antithyroid antibodies in the diagnosis ofHashimoto’s thyroiditis: comparison with histological findings. Thyroid 6: 445–450

    Article  PubMed  CAS  Google Scholar 

  • Klein I., Levey G.S. (1982) Silent thyrotoxic thyroiditis. Ann Intern Med 96: 242–244

    Article  PubMed  CAS  Google Scholar 

  • Kujat C., Dyck R., Brederhoff J., Pfannenstiel P. (1991) Diagnose und Therapie der subakuten Thyreoiditis de Quervain. Dtsch Med Wschr 116: 1439–1443

    Article  PubMed  CAS  Google Scholar 

  • Kuten A., Lubochitski R., Fishman G., Dale J., Stein M.E. (1996) Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol 61: 281–283

    Article  PubMed  CAS  Google Scholar 

  • Labib M., Gama R., Wright J., Marks V., Robins D. (1989) Dietary maladvice as a cause ofhypothyroidism and short stature. BMJ 298: 232–233

    Article  PubMed  CAS  Google Scholar 

  • Lazarus J.H., Othman S. (1991) Thyroid disease in relation to pregnancy. Clin Endocrinol 34: 91–98

    Article  CAS  Google Scholar 

  • Lecuit M., Caumes E., Bricaire F., Gatineau M., Ménégaux F., Gentilini M. (1995) Acute suppurative Salmonella enteritidis thyroiditis in a patient with the human immunodeficiency virus. Clin Infect Dis 20: 196

    Article  PubMed  CAS  Google Scholar 

  • Lio S., Pontocorvi A., Caruso M. et al. (1984) Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (de Quervain). Acta Endocrinol 106: 67–70

    PubMed  CAS  Google Scholar 

  • Marazuela M., Garcia-Buey L., Gonzalez-Fernandez B. et al.(1996) Thyroid auto immune disorders in patients with chronie hepatitis C before and during interferona-therapy. Clin Endocrinol 44: 635–642

    Article  CAS  Google Scholar 

  • Nikolai T.F., Coombs G.J., McKenzie A.K. et al. (1982) Treatment of lymphocytie thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). Arch Int Med 142: 2281–2283

    Article  CAS  Google Scholar 

  • Othman S., Phillips D.I., Parkes A.B. et al. (1990) A long-term follow up of postparturn thyroiditis. Clin Endocrin 32: 559–564

    Article  CAS  Google Scholar 

  • Peter S.A. (1992) Painful subacute thyroiditis (De Quervain’s thyroiditis). J Nat Med Assoc 84: 877–879

    CAS  Google Scholar 

  • Ramchandani D., Schindler B.A. (1993) The lithium toxie patient in the medical hospital: diagnostie and management dilemmas. Int J Psychiatry Med 23: 55–62

    Article  PubMed  CAS  Google Scholar 

  • Rapoport B. (1991) Pathophysiology of Hashimoto’s thyroiditis and hypothyroidism. Ann Rev Med 42: 91–96

    Article  PubMed  CAS  Google Scholar 

  • Robillon J.F., Sadoul J.L., Guerin P. et al.(1994) Mycobacterium avium intracellulare suppurative thyroiditis in a patient with Hashimoto’s thyroiditis. J Endocrinol Invest 17: 133–134

    PubMed  CAS  Google Scholar 

  • Roti E., Minelli R., Giuberti T. et al. (1996) Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with reeombinant inferferon-alpha. Am J Med 172: 482–487

    Article  Google Scholar 

  • Safran M., Paul T.L., Roti E. (1987) Environmental faetors affecting auto immune thyroid disease. Endocrinol Metab Clin North Am 16: 327–342

    PubMed  CAS  Google Scholar 

  • Scherbaum W.A., Paschke R. (1995) Bedeutung der Schilddrüsenantikörper für Diagnostik und Verlaufsbeurteilung von Schilddrüsenerkrankungen. Internist 36: 303–309

    PubMed  CAS  Google Scholar 

  • Scherbaum-W.A. (1987) On the clinical importance of thyroid microsomal and thyroglobulin antibody determination. Acta Endocrinol Suppl Copenh 281: 325–329

    PubMed  CAS  Google Scholar 

  • Schwartzentruber D.J., White D.E., Zweig M.H., Weintraub B.D., Rosenberg S.A. (1991) Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer 68: 2384–2390

    Article  PubMed  CAS  Google Scholar 

  • Shiegmasa C., Ueta Y., Mitani Y. et al. (1985) Chronic thyroiditis with painful tender thyroid enlargement and transient thyrotoxicosis. J Clin Endocrinol Metab 70: 385–390

    Article  Google Scholar 

  • Shigemasa C., Kouchi T., Taniguchi S., Mitani Y., Ueta Y., Yoshida A. (1991) Autoimmune thyroiditis with transient thyroxicosis: comparison between painful thyroiditis and painful thyroiditis. Horm Res 36: 9–15

    Article  PubMed  CAS  Google Scholar 

  • Singer P.A. (1991) Thyroiditis: acute, subacute, and chronic. Med Clin North Am 75: 61–77

    PubMed  CAS  Google Scholar 

  • Skuza K., Rapaport R., Fieldman R., Goldstein S. (1991) Recurrent acute suppurative thyroiditis. J Otolaryngol 20: 126–129

    PubMed  CAS  Google Scholar 

  • Szabo S.M., Allen D.B. (1989) Thyroiditis. Differentiation of acute suppurative and subacute. Case report and review of the literature. Clin Pediatr 28: 171–174

    Article  CAS  Google Scholar 

  • Tachi J., Amino N., Tamaki H. et al. (1988) Long-term follow-up and HLA association in patients with post partum hypothyroidism. J Clin Endocrinol Metab 66: 480–484

    Article  PubMed  CAS  Google Scholar 

  • Takami H., Kozakai M. (1994) Tuberculous thyroiditis: Report of a case with review of the literature. Endocr J 41: 743–747

    Article  PubMed  CAS  Google Scholar 

  • Takasu N., Komiya I., Asawa T., Nagasawa Y., Yamada T. (1990) Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto’s thyroiditis. Lancet 336: 1084–1086

    Article  PubMed  CAS  Google Scholar 

  • Tomer Y., Barbesino G., Greenberg D., Davies T.F. (1997) The immunogenetics of autoimmune diabetes and autoimmune thyroid disease TEM 8: 63–70

    PubMed  CAS  Google Scholar 

  • Tomer Y., Davies T.F. (1993) Infection, thyroid disease, and autoimmunity. Endocr Rev 14: 107–120

    PubMed  CAS  Google Scholar 

  • Tunbridge W.M. (1979) The epidemiology of hypothyroidism. Clin Endocrinol Metab 8: 21–27

    Article  PubMed  CAS  Google Scholar 

  • Tunbridge W.M., Brewis M., French J.M. et al. (1981) Natural history of autoimmune thyroiditis. Br Med J Clin Res Ed 24: 258–262, 282

    Article  Google Scholar 

  • Vanhole C., Aerssens P., Naulaers G., Casneuf A., Devlieger H., Van den Berghe G., de Zegher F. (1997) L-thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res 42: 87–92

    Article  PubMed  CAS  Google Scholar 

  • Volpe R. (1993) The management of subacute (De Quervain’s) thyroiditis. Thyroid 3: 253–255

    Article  PubMed  CAS  Google Scholar 

  • Wilichowski E., Grüters A., Kruse K. et al. (1997) Hypoparathyroidism and deafness associated with pleioplasmic large scale re arrangements of the mitochondrial DNA: a clinical and molecular genetic study of four children with Kearns Sayre syndrome. Pediatr-Res 41: 193–200

    Article  PubMed  CAS  Google Scholar 

Literatur zu Abschn. 4.8

  • Chatterjee V.K.K. (1994) Resistance to thyroid hormone-an uncommon cause of thyroxine excess and inappropriate TSH secretion. Acta med austriaca 21: 56–60

    PubMed  CAS  Google Scholar 

  • De Nayer P. (1992) The thyroid hormone receptors: molecular basis of thyroid hormone resistance. Horm Res 38: 57–61

    Article  PubMed  Google Scholar 

  • Dorey F.G., Strauch G., Gayno J.P. (1990) Thyrotoxicosis due to pituitary resistance to thyroid to thyroid hormones. Succsessful control with D-thyroxine. A study in three patients. Clin Endocrinol 32: 221

    Article  CAS  Google Scholar 

  • Dulgeroff A.J., Geffner M.E., Koyal S.N., Wong M., Hershmann J.M. (1992) Bromocriptin and Triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 75: 1071

    Article  PubMed  CAS  Google Scholar 

  • Feldkamp J., Seppel T., Horster F.A. (1995) Hyperthyroxinämie bei nichtsupprimiertem TSH. Differentialdiagnose und Therapie. Dtsch Med Wschr 120: 1323–1326

    Article  PubMed  CAS  Google Scholar 

  • Franklyn J.A. (1993) Thyroid hormone resistance syndromesare generalized and selective pituitary resistance part of the same disorder? Clin Endocrinol 38: 235–236

    Article  CAS  Google Scholar 

  • McDermott M.T., Ridgway E.C. (1993) Thyroid hormone resistance syndromes. Am J Med 94: 424–432

    Article  PubMed  CAS  Google Scholar 

  • Mixson A.J., Hauser P., Tennyson G., Renault J.C., Bodenner D.L., Weintraub B.D. (1993) Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone. 91: 2296–2300

    CAS  Google Scholar 

  • Nagaya T., Eberhardt N.L., Jameson J.L. (1993) Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations. J Clin Endocrinol Metab 77: 982–990

    Article  PubMed  CAS  Google Scholar 

  • Ueda S., Takamatsu J., Fukata S. et al. (1996) Differences in response of thyrotropin to 3,5,3’-triiodothyronine and 3,5,3’-triiodothyroacetic acid in patients with resistance to thyroid hormone. Thyroid 6: 563–570

    Article  PubMed  CAS  Google Scholar 

  • Usala, S.J., Bale A.E., Gesundheit N., Weinberger C. et al. (1988) Tight linkage between the syndrom of generalized thyroid hormone resistance and the human c-erb A ß gene. Mol Endocrinol 2: 1217

    Article  PubMed  CAS  Google Scholar 

  • Weiß R.E., Refetoff S. (1992) Thyroid hormone resistance. Ann Rev Med 43: 363–375

    Article  PubMed  Google Scholar 

  • Yen P.M., Sugawara A., Refetoff S., Chin W.W. (1992) New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone. 90: 1825–1831

    CAS  Google Scholar 

Literatur zu Abschn. 4.9

  • Beck-Peccoz P., Persani L., Mantovani S., Cortelazzi D., Asteria C. (1996) Thyrotropin-secreting pituitary adenomas. Metabolism 45: 75–79

    Article  PubMed  CAS  Google Scholar 

  • Boni G., Ferdeghini M., Bellina C.R. et al. (1995) [111In-DTPA-DPhe]-octreotide scintigraphy in functioning and nonfunctioning pituitary adenomas. Q J Nucl Med 39 (Suppl 1 ):90–93

    PubMed  CAS  Google Scholar 

  • Chanson P., Orgiazzi I., Derome P.J. et al. (1984) Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma. J Clin Endocrinol Metab 59: 542–546

    Article  PubMed  CAS  Google Scholar 

  • Feldkamp J., Seppel T., Horster F.A. (1995) Hyperthyroxinämie bei nichtsupprimiertem TSH. Differentialdiagnose und Therapie. Dtsch Med Wsehr 120: 1323–1326

    Article  CAS  Google Scholar 

  • Lee E.J., Kim K.R., Lim S.K., Lee H.C., Kim D.I., Kim S.H., Huh K.B. (1994) Reduction in size of a thyrotropin-seereting pituitary adenoma treated with octreotide acetate (somatostatin analog). Eur J Endocrinol 131: 109–112

    Article  PubMed  CAS  Google Scholar 

  • Losa M., Giovanelli M., Persani L., Mortini P., Faglia G., Beck-Peccoz P. (1996) Criteria of eure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81: 3084–3090

    Article  PubMed  CAS  Google Scholar 

  • Losa M., Magnani P., Mortini P. et al. (1994) Mod-pathol. clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Dec 7: 893–839

    Google Scholar 

  • Malarkey W.B., Kovacs K., O’Dorisio T.M. (1989) Response of a GH-and TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidenee that GH and TSH coexist in the same cell and secretory granules. Neuroendocrinology 49: 267–274

    Article  PubMed  CAS  Google Scholar 

  • Mixson A.J., Friedman T.C., Katz D.A. et al. (1993) Thyrotropinseercting pituitary carcinoma. J Clin Endocrinol Metab. 76: 529–533

    Article  PubMed  CAS  Google Scholar 

  • Takano K., Ajima-M., Teramoto A., Hata K., Yamashita N. (1995) Mechanisms of action of somatostatin on human TSH-secreting adenoma cells. Am J Physiol 268: E558–564

    PubMed  CAS  Google Scholar 

  • Tschakert H., Hokamp H.G. (I989) Zur Frage der Bestrahlung TSH-sezernierender Hypophysenadenome. Strahlenther Onkol 165: 47–51

    Google Scholar 

Literatur zu Abschn. 4.70-4.77

  • Allanic H., Fauchet R., Orgiazzi J. et al. (1990) Antithyroid drugs and Graves’ disease. A prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 70: 675–679

    Article  Google Scholar 

  • Bahn R.S., Dutton C.M., Heufelder A.E., Sarkar G. (1994) A genomic point mutation in the extracellular domain of the TSH receptor in patients with Graves’ ophthalmopathy. J Clin Endocrinol Metab 78: 256–260

    Article  PubMed  CAS  Google Scholar 

  • Barlow A.B.T., Wheatcroft N., Watson P., Weetman A.P. (1996) Association of HLA-DQA1 *0501 with Graves’ disease in English Caucasian men and women. Clin Endocrinol 44: 73–78

    Article  CAS  Google Scholar 

  • Bartalena L., Marocci C., Bogazzi F., Panicucci M., Lepri A., Pinchera A. (1989) Use of corticosteroids to prevent progression of Graves’ ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321: 1349–1352

    Article  PubMed  CAS  Google Scholar 

  • DeGroot L.J., Quintans J. (1989) The causes of auto immune thyroid disease. Endocr Rev 10: 537–562

    Article  PubMed  CAS  Google Scholar 

  • Edmonds C.J., Tellez M. (1994) Treatment of Graves’ disease by carbimazole: high dose with thyroxine compared to titration dose. Europ J Endocrinol 131: 120–124

    Article  CAS  Google Scholar 

  • Farrar J.J., Toft A.D. (1991) Iodine-131 treatment of hyperthyroidism: current issues. Clin Endocrinol 35: 207–212

    Article  CAS  Google Scholar 

  • Feldt-Rasmussen U., Schleusener H., Carayon P. (1994) Metaanalysis evaluation of the impact of thyrotropin receptor antibodies on long term remission of medical therapy for Graves’ disease. J Clin Endocrinol Metab 78: 98–103

    Article  PubMed  CAS  Google Scholar 

  • Hashizume K., Ichikawa K., Sakurai A. et aL.(1991) Administration of thyroxine in treated Graves’ disease. Effects on the level of antibodies to thyroid-stimulating receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 324: 947–53

    Article  PubMed  CAS  Google Scholar 

  • Hedley A.J., Young R.E., Jones S.J., Alexander W.D., Bewsher P.D. (1989): Antithyroid drugs in the treatment ofhyperthyroidism of Graves’ disease. Long-term follow-up of 434 patients. Clin Endocrinol 31: 209–218

    Article  CAS  Google Scholar 

  • Heuer M., Aust G., Ode-Hakim S., Scherbaum W.A. (1996) Different cytokine mRNA profiles in Graves’ disease, Hashimoto’s thyroiditis, and non auto immune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 6: 97–106

    Article  PubMed  CAS  Google Scholar 

  • Hoermann R., Schumm-Draeger P.M., Mann K. (1993): Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves’ disease by blockade of the thyrotropin receptor. Thyroid 3: 273–278

    Article  PubMed  CAS  Google Scholar 

  • Hofbauer C., Hörmann R., Heufelder E. (1996) M. Basedow: Neuester Stand zur Pathogenese, Diagnostik und Therapie. Dt Ärztebl 93:A2690–2696

    Google Scholar 

  • Kahaly G., Stover C., Otto E., Beyer J., Schuler.M (1992) Glycosaminoglycans in thyroid-associated ophtalmopathy. Autoimmunity 13: 81–88

    Article  PubMed  CAS  Google Scholar 

  • Kosugi S., Ban T., Akamizu T., Kohn L.D. (1992) Identification of separate determinants on the thyrotropin receptor reactive with Graves’ thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Mol Endocrinol 6: 168–180

    Article  PubMed  CAS  Google Scholar 

  • Luo G.L., Fan J.F., Seetharamaiah G.S. (1993) Immunization of mice with Yersinia enterocolitica leads to the induction of antithyrotropin receptor antibodies. J Immunol 151: 922–928

    PubMed  CAS  Google Scholar 

  • McIver B., Rae P., Beckett G., Wilkinson E., Gold A., Toft A. (1996) Lack of effect of thyroxine in patients with Graves’ hyperthyroidism who are treated with an antithyroid drug. N Engl J Med 334: 220–224

    Article  PubMed  CAS  Google Scholar 

  • Morgenthaler N.G., Tremble J., Huang G., Scherbaum W. A., McGregor A.M., Banga J.P. (1996) Binding of antithyrotropin receptor autoantibodies in Graves’ disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies. J Clin Endocrinol Metab 81: 700–706

    Article  PubMed  CAS  Google Scholar 

  • Prummel M., Mourits M., Berghout A., Krenning E.P., van der Gaag R., Koorneef L., Wiersinga W.M. (1989) Prednisone and cyclosporine in the treatment of severe Graves’ ophtalmopathy. N Engl J Med 321: 1353–1358

    Article  PubMed  CAS  Google Scholar 

  • Prummel M.F., Wiersinga W.M. (1993) Smoking and risk of Graves’ disease. J Am Med Assoc 269: 479–482

    Article  CAS  Google Scholar 

  • Prummel M.F., Wiersinga W.M., Mourits M.P., Koornneef L., Berghout A., van der Gaag R. (1990) Influence of abnormal thyroid function on the severity of accompanying Graves’ ophthalmopathy. Arch Int Med 150: 1098–1101

    Article  CAS  Google Scholar 

  • Reiners C. (1993) Radioiodtherapie. Indikation, Durchführung und Risiken. Dt Ärztebl:B2217–B2221

    Google Scholar 

  • Reinwein D., Benker G., Lazarus J.H., Alexander W.D., and the European Multicenter Study Group on antithyroid drug treatment (1993) A prospective randomized trial of antithyroid drug dose in Graves’ disease therapy. J Clin Endocrinol Metab 76: 1516–1521

    Article  PubMed  CAS  Google Scholar 

  • Reinwein D., Röher H-D., Emrich D. (1993) Therapie der Hyperthyreose: Aktueller Stand. Dtsch Med Wochenschr 118: 1036–1043

    Article  PubMed  CAS  Google Scholar 

  • Romaldini J.H., Bromberg N., Werner R.S. et al.(1983) Comparison of effects ofhigh and low dosage regimens of antithyroid drugs in the management of Graves’ hyperthyroidism. J Clin Endocrinol Metab 57: 563–570

    Article  PubMed  CAS  Google Scholar 

  • Schleusener H., Peters H., Fischer C., Bogner U., Finke R., Kotulla P. (1992) Ist eine Verlaufsprognose nach thyreostatischer Behandlung bei Basedow-Hyperthyreose möglich? Akt Endokr Stoffw 13: 47–52

    Google Scholar 

  • Tallstedt L., Lundell G., Blomgren H., Bring J. (1994) Does early tratment of thyroxine reduce the development of Graves’ ophtalmopathy after radioiodine treatment? Eur J Endocrinol 130: 494–497

    Article  PubMed  CAS  Google Scholar 

  • Tallstedt L., Lundell G., Torring O. et al.(1992) Occurrence of ophthalmopathy after treatment for Graves’ disease hyperthyroidism. N Engl J Med 326: 1733–1738

    Article  PubMed  CAS  Google Scholar 

  • Tomer Y., Davies T.F. (1993) Infection, thyroid disease, and autoimmunity. Endocr Rev 14: 107–120

    PubMed  CAS  Google Scholar 

  • Weetman A.P., McGregor A.M. (1994) Autoimmune thyroid disease: further developments in our und erst an ding. Endocr Rev 15: 778–830

    Google Scholar 

  • Winsa B., Adami H.O., Berstrom R. (1991) Stressfullife events and Graves’ disease. Lancet 338: 1475–1479

    Article  PubMed  CAS  Google Scholar 

  • Yanagawa T., Mangklabruks A., DeGroot L.J. (1994) Strong association between HLA-DQA1 *0501 and Graves’ disease in a male Caucasian population. J Clin Endocrinol Metab 79: 227–229

    Article  PubMed  CAS  Google Scholar 

Literatur zu Abschn. 4.12

  • Als C., Listewnik M., Ritter H.P., Rosler H. (1997) Szintigraph isches Verfahren zur Quantifizierung der morphologischen und funktionellen Veränderungen der thyreoidalen Autonomie vor und nach Radioiodtherapie. Schweiz Med Wochenschr 127: 102–106

    PubMed  CAS  Google Scholar 

  • Azizi F. (1985) Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter. J Clin Endocrinol Metab 61: 374–377

    Article  PubMed  CAS  Google Scholar 

  • Becker W., Börner W., Gruber G. (1986) Szintigraphie und Sonographie bei der Diagnostik der Schilddrüsenautonomie. Deutsch Med Wochenschr 111: 1630–1635

    Article  CAS  Google Scholar 

  • Derwahl M., Hamacher C., Russo D. et al. (1996) Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab 81: 1898–1904

    Article  PubMed  CAS  Google Scholar 

  • Emrich D., Erlenmaier U., Pohl M. et al. (1993) Determination of the autonomously functioning volume of the thyroid. Eur J Nucl Med 20: 410–414

    Article  PubMed  CAS  Google Scholar 

  • Führer D., Holzapfel H.P., Wonerow P., Scherbaum W. A., Paschke R. (1997) Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha pro tein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82: 3885–3891

    Article  PubMed  Google Scholar 

  • Hamburger J.I. (1980) Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol 50: 1089–1093

    Article  CAS  Google Scholar 

  • Holzapfel H.P., Führer D., Wonerow P., Weinland G. Scherbaum W. A., Paschke R. (1997) Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab 82: 4229–4233

    Article  PubMed  CAS  Google Scholar 

  • Kabadi U., Cech R. (1994) Therapeutic 1311 dose in hyperthyroidism: role of pretreatment with thionamide. Thyroidology 6: 87–92

    PubMed  CAS  Google Scholar 

  • Klein B., Klein E., Horster F.A. (1989) Ergebnisse der fraktionierten Radioiodtherapie bei 696 Hyperthyreosen und 690 blanden Strumen. Nuklearmedizin 28: 129–36

    PubMed  CAS  Google Scholar 

  • Kopp P., Kimura E.T., Aeschimann S., Oestreicher M., Tobler A., Fey M.F., Studer H. (1994) Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab 79: 134–139

    Article  PubMed  CAS  Google Scholar 

  • Luster M., Jacob M., Thelen M.H., Michalowski U., Deutsch U., Reiners C. (1995) Reduktion des Schilddrüsenvolumens nach Radioiodtherapie wegen funktioneller Autonomie. Nuklearmedizin 34: 57–60

    PubMed  CAS  Google Scholar 

  • Melliere D., Etienne G., Becquemin J.P. (1988) Operation for hyperthyroidism. Methods and rationale. Am J Surg 1988 155: 395–399

    Article  PubMed  CAS  Google Scholar 

  • Paschke R. (1996) Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosom al dominant non autoimmune hyperthyroidism. Exp Clin Endocrinol Diabetes 104, Suppl 4: 129–132

    Article  PubMed  CAS  Google Scholar 

  • Peter H.J., Gerber H., Studer H., Peterson M.E., Becker D.V., Groscurth P. (1991) Autonomous growth and function of cultured thyroid follicles from cats with spontaneous hyperthyroidism. Thyroid 1: 331–338

    Article  PubMed  CAS  Google Scholar 

  • Röher H.D., Goretzki P.E. (1987) Management of goiter and thyroid nodules in an area of endemic goiter. Surg-ClinNorth-Am 67: 233–249

    Google Scholar 

  • Sawin C.T., Geiler A., Wolf P.A. et al. (1994) Low thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331: 1249–1252

    Article  PubMed  CAS  Google Scholar 

  • Studer H., Derwahl M. (1995) Mechanisms of nonneoplastic endocrine hyperplasia-achanging concept: a review focused on the thyroid gland. Endocr. Rev 16: 411–426

    PubMed  CAS  Google Scholar 

  • Utiger R.D. (1994) Subclinical hyperthyroidism-just a low thyrotropin concentration, or something more. N Engl J Med 331: 1302–1303

    Article  PubMed  CAS  Google Scholar 

Literatur zu Abschn. 4.13

  • Boyages S.C. (1993) Iodine deficiency disorders. J Clin Endocrinol Metab 77: 587–591

    Article  PubMed  CAS  Google Scholar 

  • Brunn J., Block U., Ruf G. (1981) Volumetrie des Schilddrüsenlappens mittels real time-Sonographie. Dtsch Med Wochenschr 41: 1338–1340

    Article  Google Scholar 

  • Delange F. (1994) The disorders induced by iodine deficiency. Thyroid 4: 107

    Article  PubMed  CAS  Google Scholar 

  • Einenkel D., Bauch K.H., Benker G. (1992) Treatment of juvenile goitre with levothyxroxine, iodide or a combination of both: the value of ultrasound grey-scale analysis. Acta Endocrinol 127: 301

    PubMed  CAS  Google Scholar 

  • Errick J.E., Ing K.W.A., Eggo M.C., Burrow G.N. (1986) Growth and differentiation in cultured human thyroid cells: effects of epidermal growth factor and thyrotropin. In vitro Cell Dev Biol 22: 28

    Article  PubMed  CAS  Google Scholar 

  • Feldkamp J., Seppel T., Becker A., Klisch A., Schlaghecke R., Goretzki P.E., Röher H.O. (1997) Iodide or L-Thyroxine to prevent recurrent goiter in an iodine-deficient area: prospective sonographic study. World J Surg 21: 10–14

    Article  PubMed  CAS  Google Scholar 

  • Feldkamp J., Seppel T., Mühlmeyer M., Becker A., Santen R., Schlaghecke R., Horster F.A. (1996) Therapie der endemischen Struma mit Iodid oder L-Thyroxin bei älteren Patienten. Dtsch Med Wochenschr 121: 1587–1591

    Article  PubMed  CAS  Google Scholar 

  • Gärtner R. (1987) Strumatherapie mit Schilddrüsenhormon oder Iodid. Dtsch med Wochenschr 112: 987

    Article  PubMed  Google Scholar 

  • Geerdsen J.P., Frolund L. (1984) Recurrence of nontoxic goitre with and without postoperative thyroxine medication. Clin Endocrinol 21: 529

    Article  CAS  Google Scholar 

  • Glinoer D., De-Nayer P., Delange F. et al. (1995) A randomized trial for the treatment of mild iodine deficiency during pregnancy: matern al and neonatal effects. J Clin Endocrinol Metab 80: 258

    Article  PubMed  CAS  Google Scholar 

  • Goretzki P., Frilling A., Simon D., Rastegar M., Ohmann C. (1989) Growth regulation of human thyrocytes by thyrotropin, cyclic adenosine monophosphate, epidermal growth factor and insuline-like growth factor. In Growth regulation of thyroid gland and thyroid tumors. Karger, Basel, pp 56–80

    Google Scholar 

  • Grubeck-Loebenstein B., Buchan G., Sadeghi R. et al. (1989) Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J Clin Invest 83: 764

    Article  PubMed  CAS  Google Scholar 

  • Gutekunst R., Magiera U., Teichert H-M. (1993) Iodmangel in der Bundesrepublik Deutschland. Med Klinik 88: 525

    CAS  Google Scholar 

  • Gutekunst R., Smolarek H., Hasenpusch U., Stubbe P., Friedrich H-J., Wood W.G., Scriba P.C. (1986) Goitre epidemiology: Thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol 112: 494

    PubMed  CAS  Google Scholar 

  • Hampel R., Kühlberg T., Klein K. et al. (1995) Strumaprävalenz in Deutschland größer als bisher angenommen. Med Klinik 90: 324

    CAS  Google Scholar 

  • Hehrmann R. (1990) Medikamentöse Therapie der Iodmangelstruma bei Kindern, Jugendlichen, jungen Erwachsenen und Schwangeren. Sozialpädiatrie 12: 92

    Google Scholar 

  • Hintze G., Emrich D., Köbberling J. (1985) Therapy of endemic goitre. Controlled study on the effect of iodine and thyroxine. Horm metabol Res 17: 362

    Article  CAS  Google Scholar 

  • Hintze G., Windeiner S., Baumgart S., Stein H., Köbberling J. (1991) Thyroid volume and goitre prevalence in the elderly. Acta Endocrinol 124: 12

    PubMed  CAS  Google Scholar 

  • Hotze A., Bockisch A., Briele B., Horst M., Ruhlmann J., Biersack H.J. (1989) Therapie der Iodmangelstruma mit Levothyroxin und einer Kombination aus Iodid und Levothyroxin. Nuc Comp 20: 166

    Google Scholar 

  • Kahaly G., Mihaljevic V., Beyer J., Krause U. (1989) Thyroxin vs Iod und Thyroxin. Schweiz Med Wochenschr 119: 59

    PubMed  CAS  Google Scholar 

  • Köbberling J., Hintze G. (1988) Therapie der endemischen Struma. Internist 29: 550

    PubMed  Google Scholar 

  • Koutras D.A., Karaiskos K.S., Piperingos G.D. et al. (1986) Treatment of endemic goitre with iodine and thyroid hormones, alone or in combination. Endocrinologia Experimentalis 20: 57

    PubMed  CAS  Google Scholar 

  • Laurberg P. (1994) Editorial: Iodine intake-what are we aiming at? J Clin Endocrinol Metab 79: 17

    Article  PubMed  CAS  Google Scholar 

  • Leisner B., Henrich B., Knorr D., Kantlehner R. (1985) Effect of iodide treatment on iodine concentration and volume of endemic non-toxic goitre in childhood. Acta Endocrinol 108: 44

    PubMed  CAS  Google Scholar 

  • Liesenkötter K.P., Göpel W., Bogner U., Stach B., Grüters A. (1996) Earliest prevention of endemic goiter by iodine supplementation. Europ J Endocrinol 134: 443

    Article  Google Scholar 

  • Mandel S.J., Brent G.A., Larsen P.R. (1993) Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 119: 492–502

    Article  PubMed  CAS  Google Scholar 

  • Manz F., Fuchs A., Terwolbeck K., Wiese B., Lombeck I. (1993) Iodversorgungszustand gesunder Säuglinge in Deutschland. Klin Pädiatr 205: 424

    Article  PubMed  CAS  Google Scholar 

  • Olbricht Th., Hoff H-G., Benker G., Wagner R., Reinwein D. (1985) Sonographische Volumetrie der Schilddrüse zur Verlaufskontrolle hei einer Thyroxin-und Iodidbehandlung der blanden Struma. Otsch Med Wochenschr 110: 863

    Article  CAS  Google Scholar 

  • Pfannenstiel P. (1988) Therapie der endemischen Struma mit Levothyroxin und Iodid. Dtsch Med Wochenschr 113: 326.

    Article  PubMed  CAS  Google Scholar 

  • Pickardt C.R., Köbberling J. (1989) Therapie der endemischen Struma. Endokrinologie-Informationen 13: 150

    Google Scholar 

  • Saller B., Hoermann R., Ritter R. (1991) Course of thyroid iodine concentration during treatment of endemie goitre with iodine and a combination of iodine and levothyroxine. Acta Endocrinol 125: 662

    PubMed  CAS  Google Scholar 

  • Sawin C.T., Geiler A., Wolf P.A. et al. (1994) Low serum thyreotropin concentrations as a risk factor for atrial fibrillation in older persons. New Engl J Med 331: 1249

    Article  PubMed  CAS  Google Scholar 

  • Sehumm-Dräger P.M. (1993) Medikamentöse Strumatherapie. Iodid, Schilddrüsenhormone oder kombinierte Therapie. Innere Medizin 48: 592

    Google Scholar 

  • Seriba P.C., Beckers C., Bürgi A. et al. (1985) Goitre and iodine defieiency in Europe. Report of the Subcommitee for the Study of endemie Goitre and Iodine Defieieney of the European Thyroid Assoeiation. Lancet 1: 1289

    Google Scholar 

  • Stübner D., Gärtner R., Greil W. et al. (1987) Hypertrophy and hyperplasia du ring growth and involution in rats-separate bioeffects ofTSH and iodine. Acta Endocrinol 116: 537

    PubMed  Google Scholar 

  • Studer H., Peter H.J., Gerber H. (1989) Natural heterogeneity of thyroid eells: the basis for understanding thyroid function and nodular goiter growth. Endocr Rev 10: 125

    Article  PubMed  CAS  Google Scholar 

  • Uzzan B., Campos J., Cucherat M., Nony P., Boissei J.P., Perret G.Y. (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81: 4278–4289

    Article  PubMed  CAS  Google Scholar 

  • Wawsehinek O., Eber O., Petek W., Wakonig P., Gürakar A. (1985) Bestimmung der Harniodausscheidung mittels einer modifizierten Cer-Arsenit-Methode. Berichte der ÖGKC 8: 14

    Google Scholar 

  • Wilders-Truschnig M.M., Warnkroß H., Leb G. et al. (1993) The effect of treatment with levothyroxine or iodine on thyroid size and thyroid growth stimulating immunoglobulins in endemie goitre patients. Clin Endocrinol 39: 281

    Article  CAS  Google Scholar 

  • Wilgerodt A., Stach B., Keller E., Ockert C. (1990) Welchen Einfluss hat eine verbesserte alimentäre Iodversorgung. Therapiewoche 40: 2085

    Google Scholar 

Literatur zu Abschn. 4.74

  • Aust G., Eichier W., Laue S. et al. (1997) CD97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res 57: 1798–1806

    PubMed  CAS  Google Scholar 

  • Biondi B., Fazio S., Carella C. et al. (1993) Cardiac effects oflong term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77: 334–338

    Article  PubMed  CAS  Google Scholar 

  • De Groot L.J., Kaplan E.L., McCormick M., Straus F.H. (1990) Natural history, treatment and course of papillary thyroid carcinoma. Clin Endocrinol Metab 71: 414–424

    Article  Google Scholar 

  • De Groot L.J., Kaplan E.L., Straus F.H., Shukla M.S. (1994) Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 18: 123–130

    Article  Google Scholar 

  • Dralle H., Schwarzrock R., Lang W., Böcker W., Ziegler H., Schröder S., Geerlings H. (1985) Comparison of histology and immuno-histochemistry with thyroglobulin serum levels and radioiodine uptake in recurrences and metastases of differentiated thyroid carcinomas. Acta Endocrinol 108: 504–510

    PubMed  CAS  Google Scholar 

  • Eising E.G., Farahati J., Bier D. Knust E.J., Reiners C. (1995) Somatostatinrezeptorszintigraphie bei medullären Schilddrüsenkarzinomen, GEP-Tumoren und Karzinoiden. Nucl Med 34: 1–7

    CAS  Google Scholar 

  • Farahati J., Reiners C., Stuschke M., Muller S.P., Stuben G., Sauerwein W., Sack H. (1996) Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77: 172–180

    Article  PubMed  CAS  Google Scholar 

  • Feldkamp J. (1998) Endokrine Therapie und Nachsorge beim Schilddrüsenkarzinom. Schweiz Rundsch Med 87: 389–393

    CAS  Google Scholar 

  • Girelli M.E., Busnardo B., Amerio R. et al. (1985) Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppression therapy. Study on 429 patients. Europ J Nucl Med 10: 252–254

    CAS  Google Scholar 

  • Goretzki P.E., Frilling A., Ohmann C., Wins L., Grußendorf M., Röher H.D. (1989) Unterschiedliche Strategien in Diagnostik und Therapie des Schilddrüsenkarzinoms. Chirurg 60: 398–402

    PubMed  CAS  Google Scholar 

  • Hay I.D., Bergstralh E.J., Goellner J.R., Ebersold J.R., Grant C.S. (1993) Predicting outcome in papillary thyroid earcinoma: development of a reliable prognostie scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050–1058

    PubMed  CAS  Google Scholar 

  • Kerr D.J., Burt A.D., Boyle P. (1986) Prognostic factors in thyroid tumors. Br J Cancer 54: 475–482

    Article  PubMed  CAS  Google Scholar 

  • Lips C.J.M., Landsvater R.M., Höppener W.M. et al. (1994) Clinical screening as compared with DNA analysis in families with multiple endoerine neoplasia Type 2a. N Engl J Med 331: 828–835

    Article  PubMed  CAS  Google Scholar 

  • Mazzaferri E.L., Sissy M., Jhiang S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418–429

    Article  PubMed  CAS  Google Scholar 

  • Müller-Gaertner H.W., Brzac H.T., Rehpenning W. (1991) Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67: 1903–1922

    Article  Google Scholar 

  • Mulligan L.M., Kwok J.B.J., Healey C.S. et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2a (MEN 2 A). Nature 363: 458–469

    Article  PubMed  CAS  Google Scholar 

  • Panza N., de Rosa M., Lombardi G., Salvatore M. (1985) Usefulness of serum thyroglobulin at replacement withdrawal after thyroidectomy for differentiated thyroid cancer. J Nucl Med 26: 316–317

    PubMed  CAS  Google Scholar 

  • Raue F., Frank-Raue K., Grauer A. (1994) Multiple endoerine neoplasia type 2, clinical features, and screening. Endocrin. Metab Clin North Am 23: 137–156

    CAS  Google Scholar 

  • Röher H.D., Simon D., Witte J., Goretzki P.E. (1994) Principals of limited or radical surgery for differentiated thyroid cancer. Thyroidology 5: 93–96

    Google Scholar 

  • Samaan N.A., Schultz P.N., Hickey R.C., Goepfert H., Haynie T.P., Johnston D.A., Ordonez N.G. (1992) The results of various modalities of treatment of weil differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75: 714–720

    Article  PubMed  CAS  Google Scholar 

  • Sawin C.T., Geiler A., Wolf P.A. et al. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 331: 1249–1252

    Article  PubMed  CAS  Google Scholar 

  • Schelfhout L.J., Creutzberg C.L., Hamming J.F. et al. (1988) Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol. 24: 331–337

    Article  PubMed  CAS  Google Scholar 

  • Schlumberger M., Tubiana M., de Vathaire F. et al. (1986) Longterm results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63: 960–966

    Article  PubMed  CAS  Google Scholar 

  • Sherman S.T., Tielens E.T., Sostre S., Wharam M.D. Jr., Ladenson P.W. (1994) Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 78: 629–634

    Article  PubMed  CAS  Google Scholar 

  • Solbiati L., Volterrani L., Rizzatto G. et al. (1985) The thyroid gland with low uptake lesions: evaluation by ultrasound. Radiology 155: 187–191

    PubMed  CAS  Google Scholar 

  • Solomon B.L., Wartowsky L., Burman D. (1996) Current trends in the management of weil differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 81: 333–339

    Article  PubMed  CAS  Google Scholar 

  • Uzzan B., Campos J., Cucherat M., Nony P., Boissei J.P., Perret G.Y. (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81: 4278–4289

    Article  PubMed  CAS  Google Scholar 

  • Van de Velde C.J.H., Hamming J.F., Goslings B.M. et al.(1988) Report on the consensus development conference on the management of differentiated thyroid cancer in the Netherlands. Eur J Cancer Clin Oneol 24: 287–292

    Article  Google Scholar 

  • Wahl R.A., Röher H.D. (1988) Surgery for C-cell-carcinoma of the thyroid. Progr Surg 19: 100–1l2

    Google Scholar 

  • Wartofsky L. (1993) Does replacement thyroxine therapy cause osteoporosis? Adv Endocrinol Metab 4: 157–175

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Feldkamp, J., Scherbaum, W.A. (2001). Schilddrüse. In: Nawroth, P.P., Ziegler, R. (eds) Klinische Endokrinologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56784-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56784-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62970-9

  • Online ISBN: 978-3-642-56784-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics